A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects

This study will determine how morbid obesity affects the distribution and metabolism of the drug propofol. The investigators hypothesize that propofol will be distributed and metabolized differently in morbidly obese subjects as compared to normal weight subjects.

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.

Investigator(s):

Intervention(s):

  • drug : propofol

Phase: N/A

Eligibility

Ages Eligible For Study:

18 Years - 70 Years

Inclusion Criteria

- adult age (ages 18-70) - body mass index greater than 40 or between 20-25 - American Society of Anesthesiologists Class I, II, or III - undergoing elective surgical procedure requiring general anesthesia

External Links

Contact information

Primary Contact:

Jerry Ingrande, M.D., M.S. 650-723-7377

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: